Mark Atwood
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
- Epidemiology top 10%
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Influenza Virus Research Studies
Papers in
- Epidemiology 29
- Pneumonia and Respiratory Infections 19
- Respiratory viral infections research 11
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Neonatal Respiratory Health Research 2
- Co-authors
- Derek Weycker (30 shared papers)Reiko Sato (14 shared papers)Klaus-Uwe Kirchgaessler (5 shared papers)John Edelsberg (3 shared papers)Michael Kreuter (4 shared papers)Justin M. Oldham (3 shared papers)Argyrios Tzouvelekis (2 shared papers)Toby M. Maher (3 shared papers)
- Journals
- Expert Review of Vaccines (6 papers)PLoS ONE (4 papers)Value in Health (4 papers)Infectious Diseases and Therapy (3 papers)Vaccine (3 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark Atwood
41 papers receiving 639 citations
Peers
Comparison fields: 5 of 56
- Internal Medicine 42
- Epidemiology 281
- Pulmonary and Respiratory Medicine 185
- Microbiology 36
- Emergency Medicine 23
Countries citing papers authored by Mark Atwood
This map shows the geographic impact of Mark Atwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Atwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Atwood more than expected).
Fields of papers citing papers by Mark Atwood
This network shows the impact of papers produced by Mark Atwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Atwood. The network helps show where Mark Atwood may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Atwood, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 113 | |
| 2 | 2015 | 104 | |
| 3 | 2017 | 60 | |
| 4 | 2012 | 43 | |
| 5 | 2016 | 36 | |
| 6 | 2018 | 35 | |
| 7 | 2018 | 29 | |
| 8 | 2017 | 28 | |
| 9 | 2019 | 26 | |
| 10 | 2022 | 25 | |
| 11 | 2017 | 13 | |
| 12 | 2018 | 12 | |
| 13 | 2020 | 11 | |
| 14 | 2023 | 11 | |
| 15 | 2018 | 10 | |
| 16 | 2013 | 10 | |
| 17 | 2023 | 9 | |
| 18 | 2018 | 8 | |
| 19 | 2024 | 8 | |
| 20 | 2024 | 6 |
About Mark Atwood
Mark Atwood is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Internal Medicine, Cardiology and Cardiovascular Medicine and Microbiology, having authored 44 papers that have together received 650 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (19 papers), Respiratory viral infections research (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Bacterial Infections and Vaccines (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Neonatal Respiratory Health Research (2 papers). The work is most often cited by research in Internal Medicine (42 citations), Epidemiology (281 citations), Pulmonary and Respiratory Medicine (185 citations), Microbiology (36 citations) and Emergency Medicine (23 citations). Mark Atwood has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Derek Weycker, Reiko Sato, Klaus-Uwe Kirchgaessler, John Edelsberg, Michael Kreuter, Justin M. Oldham, Argyrios Tzouvelekis, Toby M. Maher, Joyce Lee and Philip L. Molyneaux. Their work appears in journals such as Expert Review of Vaccines, PLoS ONE, Value in Health, Infectious Diseases and Therapy and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.